Disc Medicine (NASDAQ:IRON – Get Free Report)‘s stock had its “overweight” rating reissued by Cantor Fitzgerald in a research note issued on Wednesday, Benzinga reports. They presently have a $85.00 price objective on the stock. Cantor Fitzgerald’s price target would indicate a potential upside of 44.07% from the company’s current price. Several other equities analysts […]
Rock Springs Capital Management LP grew its position in shares of Disc Medicine, Inc. (NASDAQ:IRON – Free Report) by 16.0% during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 363,468 shares of the company’s stock after purchasing an additional 50,000 shares during […]
Disc Medicine, Inc. (NASDAQ:IRON – Get Free Report)’s share price fell 7.1% during trading on Thursday after an insider sold shares in the company. The company traded as low as $48.68 and last traded at $48.68. 82,316 shares were traded during trading, a decline of 48% from the average session volume of 158,234 shares. The […]
Disc Medicine, Inc. (NASDAQ:IRON – Get Free Report) was the target of a large increase in short interest in September. As of September 30th, there was short interest totalling 1,040,000 shares, an increase of 77.1% from the September 15th total of 587,400 shares. Based on an average trading volume of 193,300 shares, the short-interest ratio […]
Disc Medicine, Inc. (NASDAQ:IRON – Get Free Report) was the recipient of a significant increase in short interest in the month of September. As of September 15th, there was short interest totalling 587,400 shares, an increase of 17.0% from the August 31st total of 502,000 shares. Based on an average daily volume of 211,400 shares, […]